Literature DB >> 17143284

A viable allele of Mcm4 causes chromosome instability and mammary adenocarcinomas in mice.

Naoko Shima1, Ana Alcaraz, Ivan Liachko, Tavanna R Buske, Catherine A Andrews, Robert J Munroe, Suzanne A Hartford, Bik K Tye, John C Schimenti.   

Abstract

Mcm4 (minichromosome maintenance-deficient 4 homolog) encodes a subunit of the MCM2-7 complex (also known as MCM2-MCM7), the replication licensing factor and presumptive replicative helicase. Here, we report that the mouse chromosome instability mutation Chaos3 (chromosome aberrations occurring spontaneously 3), isolated in a forward genetic screen, is a viable allele of Mcm4. Mcm4(Chaos3) encodes a change in an evolutionarily invariant amino acid (F345I), producing an apparently destabilized MCM4. Saccharomyces cerevisiae strains that we engineered to contain a corresponding allele (resulting in an F391I change) showed a classical minichromosome loss phenotype. Whereas homozygosity for a disrupted Mcm4 allele (Mcm4(-)) caused preimplantation lethality, Mcm(Chaos3/-) embryos died late in gestation, indicating that Mcm4(Chaos3) is hypomorphic. Mutant embryonic fibroblasts were highly susceptible to chromosome breaks induced by the DNA replication inhibitor aphidicolin. Most notably, >80% of Mcm4(Chaos3/Chaos3) females succumbed to mammary adenocarcinomas with a mean latency of 12 months. These findings suggest that hypomorphic alleles of the genes encoding the subunits of the MCM2-7 complex may increase breast cancer risk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17143284     DOI: 10.1038/ng1936

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  161 in total

1.  Chromatin remodeler sucrose nonfermenting 2 homolog (SNF2H) is recruited onto DNA replication origins through interaction with Cdc10 protein-dependent transcript 1 (Cdt1) and promotes pre-replication complex formation.

Authors:  Nozomi Sugimoto; Takashi Yugawa; Masayoshi Iizuka; Tohru Kiyono; Masatoshi Fujita
Journal:  J Biol Chem       Date:  2011-09-20       Impact factor: 5.157

2.  Reducing MCM levels in human primary T cells during the G(0)-->G(1) transition causes genomic instability during the first cell cycle.

Authors:  S J Orr; T Gaymes; D Ladon; C Chronis; B Czepulkowski; R Wang; G J Mufti; E M Marcotte; N S B Thomas
Journal:  Oncogene       Date:  2010-05-03       Impact factor: 9.867

Review 3.  Eukaryotic DNA replication origins: many choices for appropriate answers.

Authors:  Marcel Méchali
Journal:  Nat Rev Mol Cell Biol       Date:  2010-10       Impact factor: 94.444

4.  Cell cycle heterogeneity in the small intestinal crypt and maintenance of genome integrity.

Authors:  Steven C Pruitt; Amy Freeland; Angela Kudla
Journal:  Stem Cells       Date:  2010-07       Impact factor: 6.277

5.  Structure of the eukaryotic MCM complex at 3.8 Å.

Authors:  Ningning Li; Yuanliang Zhai; Yixiao Zhang; Wanqiu Li; Maojun Yang; Jianlin Lei; Bik-Kwoon Tye; Ning Gao
Journal:  Nature       Date:  2015-07-29       Impact factor: 49.962

Review 6.  DNA replication stress: from molecular mechanisms to human disease.

Authors:  Sergio Muñoz; Juan Méndez
Journal:  Chromosoma       Date:  2016-01-21       Impact factor: 4.316

Review 7.  Natural killer cell deficiency.

Authors:  Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2013-09       Impact factor: 10.793

Review 8.  The NF1 somatic mutational landscape in sporadic human cancers.

Authors:  Charlotte Philpott; Hannah Tovell; Ian M Frayling; David N Cooper; Meena Upadhyaya
Journal:  Hum Genomics       Date:  2017-06-21       Impact factor: 4.639

9.  Large proportion of low frequency microsatellite-instability and loss of heterozygosity in pheochromocytoma and endocrine tumors detected with an extended marker panel.

Authors:  Susan Kupka; Birgit Haack; Marty Zdichavsky; Tanja Mlinar; Christine Kienzle; Thomas Bock; Reinhard Kandolf; Stefan-Martin Kroeber; Alfred Königsrainer
Journal:  J Cancer Res Clin Oncol       Date:  2007-09-08       Impact factor: 4.553

10.  Whole-genome sequencing identifies genomic heterogeneity at a nucleotide and chromosomal level in bladder cancer.

Authors:  Carl D Morrison; Pengyuan Liu; Anna Woloszynska-Read; Jianmin Zhang; Wei Luo; Maochun Qin; Wiam Bshara; Jeffrey M Conroy; Linda Sabatini; Peter Vedell; Donghai Xiong; Song Liu; Jianmin Wang; He Shen; Yinwei Li; Angela R Omilian; Annette Hill; Karen Head; Khurshid Guru; Dimiter Kunnev; Robert Leach; Kevin H Eng; Christopher Darlak; Christopher Hoeflich; Srividya Veeranki; Sean Glenn; Ming You; Steven C Pruitt; Candace S Johnson; Donald L Trump
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.